Shared on07 Aug 25Fair value Increased 18%
Driven by a notable upward revision in consensus revenue growth forecasts and a modest improvement in net profit margin, Fortis Healthcare’s analyst price target has increased from ₹829.27 to ₹879.27. What's in the News Fortis Healthcare to hold a board meeting to review unaudited Q1 FY26 results and consider changes affecting rights of debenture holders of its INR 15.5 billion listed debentures.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Increased 0.018%
AnalystConsensusTarget has decreased revenue growth from 13.9% to 12.5%.
Shared on02 Apr 25Fair value Increased 2.93%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on12 Mar 25Fair value Decreased 9.19%
AnalystConsensusTarget has decreased future PE multiple from 57.9x to 51.6x.